One-Year Evaluation of a Neonatal Screening Program for Cystic Fibrosis in Switzerland (17.05.2013)

//doi.org/10.3238/arztebl.2013.0356

Since 1979, it has been possible to measure immunoreactive trypsinogen (IRT) as a simple and reliable screening test for cystic fibrosis (CF) in neonates (1, 2). The first newborn screening (NBS) programs for CF were introduced in New Zealand and...